Clinical Trial Update: Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of adalimumab in plaque psoriasis patients who did not have an adequate response to etanercept.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Etanercept (etanercept)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-08-24